Tri Locum Partners’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-22,471
Closed -$172K 49
2023
Q3
$172K Buy
+22,471
New +$172K 0.06% 50